NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

NVDA

175.04

-0.45%↓

AAPL

251.52

+0.13%↑

MSFT

372.3

-2.83%↓

TSM

343.1

+1.26%↑

AVGO.US

317.9

-1.48%↓

Search

Open Text Corp

Deschisă

SectorTehnologie

21.98 -4.52

Rezumat

Modificarea prețului

24h

Curent

Minim

21.81

Maxim

23.02

Indicatori cheie

By Trading Economics

Venit

21M

168M

Vânzări

53M

1.3B

P/E

Medie Sector

13.064

77.27

EPS

1.05

Randament dividend

4.68

Marjă de profit

12.672

Angajați

21,300

EBITDA

38M

463M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+38.43% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.68%

2.29%

Următoarele câștiguri

29 apr. 2026

Data viitoare de dividende

19 iun. 2026

Următoarea dată ex-dividende

5 iun. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-633M

5.7B

Deschiderea anterioară

26.5

Închiderea anterioară

21.98

Sentimentul știrilor

By Acuity

69%

31%

345 / 376 Clasament în Technology

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Open Text Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 mar. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar. 2026, 22:55 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar. 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar. 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar. 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Global Equities Roundup: Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar. 2026, 22:40 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar. 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar. 2026, 22:18 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar. 2026, 22:15 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar. 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar. 2026, 21:10 UTC

Evenimente importante

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk
Câștiguri
Evenimente importante

Basic Materials Roundup: Market Talk

Comparație

Modificare preț

Open Text Corp Așteptări

Obiectiv de preț

By TipRanks

38.43% sus

Prognoză pe 12 luni

Medie 31.88 USD  38.43%

Maxim 50 USD

Minim 26 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOpen Text Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

1

Cumpărare

7

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

26.87 / 28.19Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

345 / 376 Clasament în Tehnologie

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Open Text Corp

Open Text Corp is a Canada-based company engaged in software development sector. The Company provides a platform and suite of software products and services that assist organizations in finding, utilizing, and sharing business information from any device. The Company designs, develops, markets and sells Enterprise Information Management (EIM) software and solutions. Its EIM offerings include Enterprise Content Management (ECM), Business Process Management (BPM), Customer Experience Management (CEM), Business Network, Discovery and Analytics. Its software and services allow organizations to manage the information that flows into, out of, and throughout the enterprise as part of daily operations. Its solutions incorporate collaborative and mobile technologies and are delivered for on-premises deployment, as well as through cloud, hybrid and managed hosted services models.
help-icon Live chat